News
The report takes from HHS Secretary Robert F. Kennedy Jr’s playbook, calling out rising autism rates, the vaccine schedule ...
Upperton Pharma Solutions is a winner in the Business Expansion category in the 2025 Pharmaceutical Excellence Awards.
Philadelphia-based biotech Vivodyne has raised $40 million in series A funding to advance its fully robotic, AI-powered ...
The president rolled out a plan that was less aggressive than his first-term effort in 2020, surprising analysts who were bracing for something tougher.
Onesource Specialty, a newly demerged pharma CDMO, is set to benefit from the $150 billion GLP-1 weight-loss drug boom with ...
As geopolitical tensions prompt global pharmaceutical giants to pivot away from China, India's Contract Development and ...
The company also expects R&D spending to rise to 6–8% of sales, reflecting its commitment to pipeline expansion and ...
The European Commission plans to create a public-private fund of at least 10 billion euros ($11.3 billion) to help tech ...
AI adoption in pharma can be slow, but failing to scale these new tools across your organization is a missed opportunity. Here’s how to do it.
The 14th edition of the Indian Pharma Fair (IFF) is set to take place on November 7th and 8th in Bengaluru, Karnataka. This ...
The company will engage in BIO One-on-One Partnering™ meetings as it advances Phase 1 for Ketamir-2, prepares Phase IIa study in neuropathic pain, and finalizes filings for SKNY acquisition.
Data compiled by fund manager Aberdeen and broker Peel Hunt show 61 firms, worth a combined £12.3bn, have announced plans to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results